A detailed history of Jane Street Group, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 59,802 shares of ARCT stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,802
Previous 73,112 18.2%
Holding current value
$1.01 Million
Previous $1.78 Million 22.02%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.08 - $25.38 $240,644 - $337,807
-13,310 Reduced 18.2%
59,802 $1.39 Million
Q2 2024

Aug 14, 2024

BUY
$24.35 - $44.39 $615,933 - $1.12 Million
25,295 Added 52.9%
73,112 $1.78 Million
Q1 2024

May 15, 2024

SELL
$31.23 - $42.99 $735,122 - $1.01 Million
-23,539 Reduced 32.99%
47,817 $1.61 Million
Q4 2023

Feb 14, 2024

SELL
$17.71 - $32.97 $134,737 - $250,835
-7,608 Reduced 9.63%
71,356 $2.25 Million
Q3 2023

Nov 14, 2023

BUY
$25.44 - $37.35 $710,895 - $1.04 Million
27,944 Added 54.77%
78,964 $2.02 Million
Q2 2023

Aug 14, 2023

BUY
$23.94 - $32.36 $40,745 - $55,076
1,702 Added 3.45%
51,020 $1.46 Million
Q1 2023

May 15, 2023

SELL
$14.72 - $23.97 $530,273 - $863,495
-36,024 Reduced 42.21%
49,318 $1.18 Million
Q4 2022

Feb 14, 2023

BUY
$14.14 - $23.06 $767,660 - $1.25 Million
54,290 Added 174.84%
85,342 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$13.05 - $22.13 $76,681 - $130,035
-5,876 Reduced 15.91%
31,052 $461,000
Q2 2022

Aug 16, 2022

BUY
$12.26 - $31.17 $288,342 - $733,087
23,519 Added 175.4%
36,928 $581,000
Q1 2022

May 17, 2022

SELL
$17.64 - $39.57 $496,460 - $1.11 Million
-28,144 Reduced 67.73%
13,409 $362,000
Q4 2021

Feb 15, 2022

SELL
$34.2 - $47.56 $470,079 - $653,712
-13,745 Reduced 24.86%
41,553 $1.54 Million
Q3 2021

Nov 16, 2021

BUY
$27.88 - $58.25 $829,374 - $1.73 Million
29,748 Added 116.43%
55,298 $2.64 Million
Q2 2021

Aug 16, 2021

SELL
$25.79 - $42.11 $1.58 Million - $2.58 Million
-61,276 Reduced 70.57%
25,550 $865,000
Q4 2020

Feb 17, 2021

SELL
$34.61 - $123.66 $2.31 Million - $8.25 Million
-66,730 Reduced 43.46%
86,826 $3.77 Million
Q3 2020

Nov 17, 2020

BUY
$37.49 - $63.19 $2.45 Million - $4.14 Million
65,468 Added 74.32%
153,556 $6.59 Million
Q2 2020

Aug 17, 2020

BUY
$12.66 - $58.27 $883,174 - $4.06 Million
69,761 Added 380.65%
88,088 $4.12 Million
Q1 2020

May 15, 2020

BUY
$9.31 - $18.26 $170,624 - $334,651
18,327 New
18,327 $249,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $451M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.